AstraZeneca: Oncology Dominance Justifies New All-Time Highs [Seeking Alpha]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Seeking Alpha
The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular franchises. For example, sales of Tagrisso, an EGFR inhibitor for the treatment of people with non-small cell lung cancer, reached $1.86 billion in Q3, up 11.4% year-on-year. And coupledwith significant progress in its baxdrostat and blockbuster therapy Imfinzi, Icontinue to cover AstraZeneca with a 'Buy' rating. PeopleImages/iStock via Getty Images Since my last article, "AstraZeneca: Oncology Breakthroughs And Farxiga Surge Excite Investors," AstraZeneca shares (NASDAQ: AZN ) (OTCPK: AZNCF ) have risen 26.9%. In the 1-D chart, the first thing I saw was the bears trying to push its stock This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my ow
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- What Makes AstraZeneca (AZN) a Strong Growing Company? [Yahoo! Finance]Yahoo! Finance
- AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference [Yahoo! Finance]Yahoo! Finance
- Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 1/8/26 - Form 6-K
- 1/2/26 - Form 6-K
- 12/22/25 - Form 6-K
- AZN's page on the SEC website